What skin side effects can Keytruda (pembrolizumab) cause?
Keytruda can trigger immune system–related inflammation throughout the body, including the skin. Reported skin-related effects can range from mild rashes to more serious immune reactions. Common skin complaints include rash, itching (pruritus), and skin redness or swelling that can occur during treatment.
Because Keytruda is an immunotherapy, skin side effects can also signal a more significant immune reaction that needs prompt medical attention.
When to get urgent care for Keytruda rash or skin symptoms
Seek urgent medical help right away (or contact your oncology team urgently) if skin symptoms come with any of the following:
- Blistering or peeling skin
- Sores or ulcers in the mouth, eyes, or genitals
- Fever, feeling very unwell, or rapidly worsening rash
- Widespread rash that spreads quickly or involves mucous membranes (mouth/eyes)
- Signs of a severe allergic-type reaction (rapid swelling, trouble breathing)
These patterns can suggest serious immune-related skin conditions that require immediate treatment and possible interruption of Keytruda.
How doctors decide whether a skin reaction is “immune-related” from Keytruda
Clinicians typically connect skin symptoms to Keytruda when they:
- Start after beginning treatment or after dose changes
- Are new, progressive, and not explained by another cause (like new soaps, medications, or infections)
- Fit immune-mediated patterns (for example, specific rash morphology, involvement of mucous membranes, or systemic symptoms)
- Improve after holding Keytruda and using appropriate supportive or anti-inflammatory treatment, such as corticosteroids, per oncology guidance
Your prescriber will also consider recent new meds, infections, and underlying skin conditions.
Treatment: what helps skin side effects while on Keytruda?
Management depends on how severe the skin reaction is. Options often include:
- Topical therapies and antihistamines for mild itching or limited rash
- Oral or IV corticosteroids for moderate-to-severe immune skin reactions
- Holding Keytruda temporarily if symptoms are more than mild
- Stopping Keytruda permanently in the most severe cases, depending on the diagnosis and risk assessment
Your oncology team will tailor treatment to severity and rule out infections before escalating immunosuppression.
Can skin side effects happen long after starting Keytruda?
Yes. Immune-related side effects can appear at different times during therapy. They may begin soon after treatment starts, but they can also show up later, including after some time on therapy. If you develop a new or worsening rash while on Keytruda (or soon after stopping), treat it as potentially treatment-related and report it promptly.
Does having skin side effects mean Keytruda is working?
Skin reactions sometimes occur in patients receiving immunotherapy, but skin side effects are not a reliable marker of whether Keytruda is working for any individual. The safest approach is to focus on managing symptoms and reporting changes so your clinician can adjust treatment appropriately.
What patients ask most: “Is my rash from Keytruda or something else?”
A Keytruda skin reaction is more likely if the rash is new, progressive, and temporally linked to starting or continuing treatment, especially if there are no clear alternative triggers. Your clinician may want to check for drug interactions, contact dermatitis (from skincare or detergents), and infections. If there are red flags like blistering or mouth sores, urgent evaluation is important.
If you want, share:
1) what your rash looks like (itchy vs painful, flat vs raised, any blisters),
2) where it is on your body, and
3) when it started relative to your last Keytruda dose,
and I can help you map it to the kind of urgency and questions to bring to your oncology team.